SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0269881107082898v1
22/6/681    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Viana, A. F.
Right arrow Articles by do Rego, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viana, A. F.
Right arrow Articles by do Rego, J.-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Effects of acute or 3–day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress–induced increase in serum and brain corticosterone levels

Alice F. Viana1, Stela M.K. Rates2, Bertrand Naudin3, Francois Janin3, Jean Costentin3, and Jean–Claude do Rego4

1 Unité de Neuropsychopharmacologie Expérimentale, Faculté de Médecine and Pharmacie, Rouen Cedex, France and Programa de Pós–Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
2 Programa de Pós–Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
3 Unité de Neuropsychopharmacologie Expérimentale, Faculté de Médecine and Pharmacie, Rouen Cedex, France.
4 Unité de Neuropsychopharmacologie Expérimentale, Faculté de Médecine and Pharmacie, Rouen Cedex, France

* To whom correspondence should be addressed.


   Abstract

Since depressive patients present alterations in the hypothalamopituitary– adrenal (HPA) axis that are normalised by antidepressants, this HPA axis has been considered as a target of their actions. We have investigated the mechanism of action of a cyclohexane extract of Hypericum caprifoliatum (HCP), which displays antidepressant like activity, by studying, in mice, the influence of HCP and of two established antidepressant drugs, imipramine and bupropion, administered either acutely or semi–chronically (once a day, three consecutive days), on serum and brain cortex corticosterone levels, either in basal conditions or shortly after a forced–swimming session (FSS). Administered acutely, imipramine (20mg/kg, per os (p.o.)), bupropion (30mg/kg, p.o.) and HCP (360mg/kg, p.o.) significantly reduced the immobility time and had no effects on FSS–induced increase of serum and cortical corticosterone levels. Conversely, 3 days repeated treatment with imipramine or bupropion resulted in a significant reduction of immobility time and FSSinduced increase of serum and cortical corticosterone levels. In a different way, repeated treatment with HCP significantly reduced the immobility time and only cortical corticosterone levels in stressed mice. These results indicate that short–term treatments with antidepressants are sufficient to induce modifications in the HPA axis reactivity to stress; and that apparently HCP has an influence on corticosterone levels by a mechanism diverse from the other tested antidepressants.

Key Words: brain cortex and serum corticosterone, forced–swimming stress, imipramine, bupropion, Hypericum caprifoliatum, mouse

First published on February 28, 2008, doi:10.1177/0269881107082898

Journal of Psychopharmacology 2008;22:681.

A more recent version of this article appeared on August 1, 2008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement